OXCARBAZEPINE
- Product NDC
- 51672-1393
- 11-digit product format
- 516721393
- Labeler code
- 51672
- Product ID
- 51672-1393_440646d8-f538-5968-e063-6394a90ab7cd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OXCARBAZEPINE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA078734
- Marketing category
- ANDA
- Marketing start
- 2025-08-06
- Substance
- OXCARBAZEPINE
- Active strength
- 60 mg/mL
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OXCARBAZEPINE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXCARBAZEPINE | 60 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VZI5B1W380 |
| Rxcui | 283536 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51672-1393-1 | OXCARBAZEPINE | 1 in 1 CARTON | SUSPENSION | 1 | | 8 |
| 51672-1393-1 | OXCARBAZEPINE | 250 mL in 1 BOTTLE, GLASS | SUSPENSION | 250 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51672-1393 | OXCARBAZEPINE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | Current NDC, 2 package rows | 20250125_9d5ba8a3-d1ea-4d5b-aafd-3a7ba2d4746c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 51672-1393-1 | 51672139301 | 1 BOTTLE, GLASS in 1 CARTON (51672-1393-1) / 250 mL in 1 BOTTLE, GLASS | 2025-08-06 | No | No | Historical |